Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,57 USD | -0,63% | +17,16% | +97,98% |
Omzet 2024 * | 81,85 mln. 75,87 mln. | Omzet 2025 * | 73,92 mln. 68,52 mln. | Marktkapitalisatie | 390 mln. 362 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -96 mln. -88,99 mln. | Nettowinst (verlies) 2025 * | -120 mln. -111 mln. | EV/omzet 2024 * | 4,76 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 5,28 x |
K/w-verhouding 2024 * |
-13,2
x | K/w-verhouding 2025 * |
-6,87
x | Werknemers | 449 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 15,06% |
Recentste transcriptie over Adaptimmune Therapeutics plc
1 dag | -0,63% | ||
1 week | +17,16% | ||
1 maand | -2,48% | ||
3 maanden | +127,50% | ||
6 maanden | +99,85% | ||
Lopend jaar | +97,98% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 57 | 01-01-08 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01-03-15 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 01-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/11 |
Andrew Allen
BRD | Director/Board Member | 57 | 01-06-23 |
David Mott
CHM | Chairman | 58 | 01-09-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,57 | -0,63% | 1 066 310 |
27-03-24 | 1,58 | +3,95% | 1 184 494 |
26-03-24 | 1,52 | +5,56% | 1 194 956 |
25-03-24 | 1,44 | 0,00% | 1 175 504 |
22-03-24 | 1,44 | +7,46% | 1 671 980 |
uitgestelde koers Nasdaq, 28 maart 2024 om 20:59 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+97,98% | 390 mln. | |
+2,73% | 108 mld. | |
+9,59% | 104 mld. | |
+6,58% | 23,66 mld. | |
-12,59% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,36% | 18,2 mld. | |
-13,29% | 16,19 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,22 mld. |